Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 This is with reference to the 46th Annual General Meeting ('AGM') of the Company held on Tuesday, 18th August, 2020 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Please find enclosed herewith the details regarding the brief proceedings of the 46th Annual General Meeting (AGM) of the Company and the details regarding the voting results of the business transacted at the said AGM in the prescribed format. Further, we are also enclosing the Report of the Scrutinizer on remote e-voting and e-voting during the AGM. You are requested to take a note of the same.
18-08-2020

Buy ALKEM Laboraties; target of Rs 3665: Motilal Oswal

 Motilal Oswal is bullish on ALKEM Laboraties recommended buy rating on the stock with a target price of Rs 3665 in its research report dated August 08, 2020.
11-08-2020
Bigul

Earnings Call Transcript - Q1FY21 for Alkem Labs

 Conference Call with Alkem Laboratories Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.
10-08-2020

Accumulate Alkem Laboratories; target of Rs 2920: Dolat Capital

 Dolat Capital recommended accumulate rating on Alkem Laboratories with a target price of Rs 2920 in its research report dated August 08, 2020.
09-08-2020
Bigul

Alkem Labs Q1 profit jumps 2-fold to Rs 423.2 cr, revenue up at Rs 2,004 cr

 Consolidated revenue from operations of the company stood at Rs 2,003.49 crore for the quarter under consideration. It was Rs 1,849.50 crore for the same period a year ago, it added
07-08-2020
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

 We refer to our earlier communication dated 25th June, 2020 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June, 2020) starting from 29th June, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ended 30th June, 2020 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter ended 30th June, 2020 having been communicated to the Stock Exchanges, today i.e. 07th August, 2020, the trading window shall open on 10th August, 2020.
07-08-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY21 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same.
07-08-2020
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY21 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same.
07-08-2020
Bigul

Alkem Laboratories Ltd - 539523 - Financial Results For The Quarter Ended 30Th June 2020

 In continuation of our letter dated 27th July, 2020 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') the Board of Directors of the Company, at its meeting held today, i.e. 07th August, 2020, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2020. Accordingly we are enclosing herewith the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2020 and the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1.20 pm. Kindly take the same on record.
07-08-2020
Bigul

Alkem Laboratories Ltd - 539523 - Outcome Of The Board Meeting Dated 7Th Aug 2020

 The Board of Directors at its meeting held today i.e. 07th August, 2020, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2020. Accordingly, we are enclosing herewith Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2020 and the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11 am and concluded at 1.20pm.
07-08-2020
Next Page
Close

Let's Open Free Demat Account